Testosterone

DB00624ApprovedInvestigationalSmall moleculeAndrogens

Testosterone is a hormone used to treat hypogonadism, breast carcinoma in women, or the vasomotor symptoms of menopause. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.

Chemical structure of Testosterone
Mechanism
Curator reviewed · 19 references
Primary indication
Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.Curator reviewed · 11 structured indications
Formula / weight
C19H28O2 · 288.4244 g/mol (avg)
First approval
Canada, 2012 · United States, 1995
Also known as
Virosterone
Code names
4-08-00-00979 · BRN 3170544 · CCRIS 7082 · EINECS 206-253-5 · EINECS 227-712-6 · NSC-17591 · NSC-9700
Brand names
  • Androgel
  • Axiron
  • Fortesta
  • Natesto
  • Striant
  • Testim
  • Testopel
  • Vogelxo

Resolves to

Structure
InChIKeyMUMGGOZAMZWBJJ-DYKIIFRCSA-NSMILES[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C

What you can answer from here — as of September 12, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,516Drug interactionsStructured to mechanism, not free text
Sign in
291Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
262Marketed productsAcross 10 countries and 77 labellers
Sign in
2ATC codesIncluding every combination product, plus 37 drug categories
Sign in
72+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Testosterone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account